U.S. Oil and Gas Stock News

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see ReposiTrak...

VeriSign (NasdaqGS:VRSN) announced that its Senior VP & CTO will present at RSA Conference 2026. The appearance places the company on the program of one of the cybersecurity sector’s best known annual events. For investors watching NasdaqGS:VRSN, RSA is a high visibility stage that focuses heavily on security infrastructure, encryption and internet trust. VeriSign’s core role in domain name registry services and internet infrastructure means its voice at this event is closely tied to...

Millicom International Cellular S.A. has convened its May 20, 2026 AGM in Luxembourg, where shareholders previously approved the 2025 accounts and a proposed US$3.00 per share dividend to be paid in four equal installments between July 2026 and April 2027, alongside a new share repurchase plan. By pairing a multi‑installment dividend with authorization for buybacks, Millicom is signaling a clear emphasis on flexible capital returns and balance sheet management. We’ll now examine how the...

Cintas, ticker NasdaqGS:CTAS, has agreed to acquire UniFirst in a cash and stock transaction. The deal is set to combine two major players in uniforms and facility services, pending customary approvals. The transaction is designed to expand Cintas reach across customers, service routes, and product offerings. Cintas comes into this planned acquisition with shares at $168.85 and a record of returns over multi year periods. The stock is down 7.1% over the past week, 15.0% over the past month,...

Agilent Technologies, Inc. ( NYSE:A ) is about to trade ex-dividend in the next three days. The ex-dividend date is...

LGI Homes has opened Goldfields Ranch in Linda, California, a 499-homesite community featuring three- to five-bedroom single-family homes with its CompleteHome Plus upgrade package included in the price, plus a planned 4.25-acre park and quick access to CA-70 and nearby shopping and recreation. This large-scale Sacramento–Yuba City area community, with move-in-ready homes starting in the US$450,000s and extensive onsite amenities, underscores LGI Homes’ continued push into entry-level and...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Franklin...

If you are wondering whether Novo Nordisk’s current share price offers value or carries more risk than reward, it starts with understanding how the market is now treating this long established pharmaceutical name. The stock last closed at US$36.40, with returns of a 1.8% decline over 7 days, 5.7% decline over 30 days, 30.5% decline year to date, 47.1% decline over 1 year, and 52.5% decline over 3 years, while the 5 year return sits at 13.2%. These moves have come as attention around Novo...

Index removal puts Masco in focus Masco (MAS) was recently removed from the FTSE All-World Index (USD). This type of event can prompt mechanical selling by index-tracking funds and bring short term trading pressures onto the stock. See our latest analysis for Masco. At a share price of US$60.19, Masco has had a 1 month share price return of 18.53% decline and a 1 year total shareholder return of 12.96% decline. However, the 3 year total shareholder return of 31.17% suggests longer term...

ADMA Biologics (NasdaqGM:ADMA) issued a public response to a short-seller report from Culper Research. The company disputed the accuracy of the allegations and reiterated its focus on regulatory compliance. This exchange centers on claims about ADMA Biologics' business practices and disclosures. For investors, this is notable because ADMA Biologics operates in a tightly regulated biopharmaceutical space where compliance is central to its plasma based therapies business. When a short-seller...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Earnings results and 2026 outlook draw fresh focus to GDS Holdings GDS Holdings (GDS) is back in the spotlight after reporting fourth quarter and full year 2025 results that combined higher revenue with sharply weaker profitability, along with 2026 revenue guidance pointing to further top line expansion. See our latest analysis for GDS Holdings. The share price reaction to the latest earnings and 2026 guidance has been negative in the short term, with a 1 day share price return of a 6.69%...

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...

Why Carlyle Group Stock Is On Investors’ Radar Carlyle Group (CG) has drawn fresh attention after a period of weaker share performance, with the stock declining about 8% over the past month and roughly 23% over the past 3 months. At a last close of US$46.77, the firm carries a market value of about US$16.98b, supported by reported revenue of US$4,031.6m and net income of US$808.7m across its global investment platform. See our latest analysis for Carlyle Group. The recent 1 month share price...

Wondering if Universal Technical Institute at US$37.96 is priced for its past, its future, or a bit of both? This article focuses squarely on what that share price could mean for value minded investors. The stock has logged returns of 1.7% over 7 days, 9.4% over 30 days, 52.8% year to date, and 43.2% over the last year, which naturally raises questions about what expectations are now built into the current price. Recent attention on Universal Technical Institute has centered on its share...

Arlo Technologies recently reported a past quarter in which revenue grew 16.2% year on year, beating analyst forecasts by 4.2% and delivering earnings per share above expectations for both the reported period and its next-quarter guidance. The company also moved from negative to positive full-year earnings per share over the last five years, highlighting a key profitability inflection that builds on its 8.2% annualized revenue growth in the same period. Next, we will examine how Arlo’s...

Intellicheck, Inc. ( NASDAQ:IDN ) recently posted some strong earnings, and the market responded positively. We did...

Why 10x Genomics Is Back in Focus 10x Genomics (TXG) is back on investor watchlists after two catalysts: its role in Bioptimus’ new STELA spatial tissue atlas, and steady share purchases by high profile fund manager Cathie Wood. See our latest analysis for 10x Genomics. The recent partnership on the STELA initiative and continued buying from Cathie Wood have arrived while the share price sits at US$20.43, with a 90 day share price return of 23.89% and a 1 year total shareholder return of...

Over the last 7 days, the United States market has experienced a 1.6% decline, though it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.

Over the last 7 days, the United States market has experienced a 1.6% drop, yet it has shown resilience with a 15% increase over the past year and expectations for earnings to grow by 16% annually in the coming years. In this context of fluctuating short-term performance but promising long-term growth prospects, identifying high growth tech stocks that can capitalize on these trends becomes essential for investors seeking potential opportunities.

Wondering whether PROG Holdings at around US$29.02 actually offers value, or if the recent share price leaves limited upside? This breakdown helps you frame that question with numbers, not guesswork. The stock is up 3.8% over the last week, sits at a 21.7% decline over 30 days, and is around 1.2% lower year to date. The 1 year and 3 year returns are 7.7% and 33.6%, and the 5 year return is a 33.8% decline. Recent headlines around PROG Holdings have focused on its position within the broader...

Over the last 7 days, the United States market has experienced a 1.6% decline, yet it has shown resilience with a 15% rise over the past year and an anticipated earnings growth of 16% annually in the coming years. In this environment, identifying stocks that may be underestimated requires looking beyond short-term fluctuations to find companies with strong fundamentals and potential for long-term value appreciation.